Abstract Immunotherapy is leading the transformation in cancer treatment, but its response rate remains low, and there is a scarcity of immune targets that can produce lasting effects. Multi-omics data is widely used in immunotherapy. However, traditional analysis methods often struggle to uncover hidden correlations within the data, limiting the exploration of potential immunotherapy targets.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Genshen
Contact Genshen, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack